Infliximab Treatment in a Patient with Systemic Sclerosis Associated with Lung Fibrosis and Pulmonary Hypertension

Publisher： Karger

E-ISSN： 1423-0356|75|3|346-349

ISSN： 0025-7931

Source： Respiration, Vol.75, Iss.3, 2005-12, pp. : 346-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pulmonary hypertension in scleroderma

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 3, 2015-03 ,pp. : 248-254

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 11, 2015-11 ,pp. : 1134-1140

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of dyskeratosis congenita‐associated pulmonary fibrosis with danazol

By  

PEDIATRIC PULMONOLOGY, Vol. 50, Iss. 12, 2015-12 ,pp. : E48-E51

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Treatment of Sarcoidosis-Associated Pulmonary Hypertension with Bosentan

By  

Respiration, Vol. 75, Iss. 2, 2005-11 ,pp. : 211-214

Karger

Access to resources Recommend Favorite

High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 5, 2015-06 ,pp. : 524-532

John Wiley & Sons Inc

Access to resources Recommend Favorite